secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dianthus Therapeutics, Inc. /DE/ (DNTH)
CIK:        0001690585
Form:       8-K
Filed at:   2024-12-12T23:59:59+00:00
Accession:  0000950170-24-135775
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dianthus Therapeutics posts updated corporate presentation; no specific financial or operational news disclosed
--------------------------------------------------------------------------------

- Filed under Item 8.01; presentation posted on IR section of website dated December 2024.
- No new financial results, guidance, or material events are provided in the filing text.
- The exhibit (Ex-99.1) is a corporate presentation slide deck, but its content is not summarized in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690585/000095017024135775/0000950170-24-135775-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690585/000095017024135775/dnth-20241212.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-135775

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer